BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2940951)

  • 1. Cromolyn inhibition of mediator release in mast cells derived from mouse bone marrow.
    Marquardt DL; Walker LL; Wasserman SI
    Am Rev Respir Dis; 1986 Jun; 133(6):1105-9. PubMed ID: 2940951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
    Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF
    J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mast cell mediator release by 5-amino-4-imidazolecarboxamide riboside.
    Marquardt DL; Gruber HE
    Biochem Pharmacol; 1986 Dec; 35(24):4415-21. PubMed ID: 2947580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and biochemical characterization of rat bone marrow derived mast cells.
    Broide DH; Metcalfe DD; Wasserman SI
    J Immunol; 1988 Dec; 141(12):4298-305. PubMed ID: 2974057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of mast cell responses to adenosine by agents that alter protein kinase C activity.
    Marquardt DL; Walker LL
    Biochem Pharmacol; 1990 Jun; 39(12):1929-34. PubMed ID: 2141257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone.
    Benhamou M; Ninio E; Salem P; Hieblot C; Bessou G; Pitton C; Liu FT; Mencia-Huerta JM
    J Immunol; 1986 Feb; 136(4):1385-92. PubMed ID: 2935578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids.
    Robin JL; Seldin DC; Austen KF; Lewis RA
    J Immunol; 1985 Oct; 135(4):2719-26. PubMed ID: 3161947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin inhibits mast cell mediator release.
    Marquardt DL; Gruber HE; Walker LL
    J Pharmacol Exp Ther; 1987 Jan; 240(1):145-9. PubMed ID: 2949069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta 1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation.
    Broide DH; Wasserman SI; Alvaro-Gracia J; Zvaifler NJ; Firestein GS
    J Immunol; 1989 Sep; 143(5):1591-7. PubMed ID: 2527268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.
    Razin E; Mencia-Huerta JM; Stevens RL; Lewis RA; Liu FT; Corey E; Austen KF
    J Exp Med; 1983 Jan; 157(1):189-201. PubMed ID: 6184439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of mast cell responsiveness to adenosine by pertussis toxin.
    Marquardt DL; Walker LL
    Biochem Pharmacol; 1988 Oct; 37(20):4019-25. PubMed ID: 2847750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminophylline exposure alters mouse bone marrow-derived mast cell adenosine responsiveness.
    Marquardt DL; Gruber HE; Wasserman SI
    J Allergy Clin Immunol; 1986 Sep; 78(3 Pt 1):462-9. PubMed ID: 3020110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidylcholine induces mast cell secretion and protein kinase C activation.
    Marquardt DL; Walker LL
    J Allergy Clin Immunol; 1991 Nov; 88(5):721-30. PubMed ID: 1835466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with phorbol esters abrogates mast cell adenosine responsiveness.
    Marquardt DL; Walker LL
    J Immunol; 1989 Feb; 142(4):1268-73. PubMed ID: 2536770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgE-mediated release of rat mast cell protease II, beta-hexosaminidase and leukotriene C4 from cultured bone marrow-derived rat mast cells.
    MacDonald AJ; Haig DM; Bazin H; McGuigan AC; Moqbel R; Miller HR
    Immunology; 1989 Jul; 67(3):414-8. PubMed ID: 2527196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative functional characterization of mouse bone marrow-derived mast cells and peritoneal mast cells in response to non-immunological stimuli.
    Singh R; Kumar P; Gupta PP
    Indian J Exp Biol; 2001 Apr; 39(4):323-8. PubMed ID: 11491575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells.
    Mencia-Huerta JM; Razin E; Ringel EW; Corey EJ; Hoover D; Austen KF; Lewis RA
    J Immunol; 1983 Apr; 130(4):1885-90. PubMed ID: 6300233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine receptors on mouse bone marrow-derived mast cells: functional significance and regulation by aminophylline.
    Marquardt DL; Walker LL; Wasserman SI
    J Immunol; 1984 Aug; 133(2):932-7. PubMed ID: 6330205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The culture of mouse bone marrow-derived mast cells (BMMC) and the anaphylactic release of chemical mediators].
    Yamamura H; Ohkawa E; Kohno S; Ohata K
    Arerugi; 1992 Sep; 41(9):1367-79. PubMed ID: 1280088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.